COSM
Cosmos Holdings Inc. [COSM] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
COSM Stock Summary
Top 10 Correlated ETFs
COSM
Top 10 Correlated Stocks
COSM
In the News
COSM Financial details
Company Rating
Neutral
Market Cap
11.94M
Income
-15.61M
Revenue
49.59M
Book val./share
3.54
Cash/share
0.19
Dividend
-
Dividend %
-
Employees
102
Optionable
No
Shortable
Yes
Earnings
15 May 2024
P/E
-1.03
Forward P/E
-
PEG
0.12
P/S
0.35
P/B
0.36
P/C
3.2
P/FCF
-0.53
Quick Ratio
1.41
Current Ratio
2.06
Debt / Equity
0.24
LT Debt / Equity
0.09
-
-
EPS (TTM)
-1.48
EPS next Y
-
EPS next Q
-
EPS this Y
-40.84%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-15.88%
Revenue last 5Y
6.31%
Revenue Q/Q
3.72%
EPS Q/Q
197.68%
-
-
-
-
SMA20
-6.94%
SMA50
-35.58%
SMA100
-36.79%
Inst Own
18.84%
Inst Trans
1.23%
ROA
-22%
ROE
-36%
ROC
-0.32%
Gross Margin
7%
Oper. Margin
-31%
Profit Margin
-31%
Payout
-168%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.61-4.05
52W High
-
52W Low
-
RSI
31.13
Rel Volume
0.27
Avg Volume
286.83K
Volume
76.31K
Perf Week
-11.94%
Perf Month
-20.25%
Perf Quarter
-40.42%
Perf Half Y
-49.78%
-
-
-
-
Beta
2.853
-
-
Volatility
0.04%, 0.05%
Prev Close
-3.54%
Price
0.6077
Change
-5.42%
COSM Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 69.67 | 74.73 | 104.38 | 85.61 | 26.11 | |
| Net income per share | -17.02 | -6.21 | 1.55 | -12.12 | -7.17 | |
| Operating cash flow per share | -2.92 | -9.02 | -21.67 | -10.8 | -7.71 | |
| Free cash flow per share | -3.87 | -10.29 | -21.89 | -12.16 | -7.91 | |
| Cash per share | 6.73 | 0.53 | 1.6 | 0.45 | 10.77 | |
| Book value per share | -6.23 | -12.17 | -7.84 | 6.67 | 20.57 | |
| Tangible book value per share | -6.79 | -12.67 | -8.27 | 5.92 | 20.2 | |
| Share holders equity per share | -6.23 | -12.17 | -7.84 | 6.67 | 20.57 | |
| Interest debt per share | 43.94 | 39.59 | 65.63 | 46.74 | 8.29 | |
| Market cap | 53.23M | 29.2M | 2.71M | 55.35M | 8.79M | |
| Enterprise value | 68.94M | 48.45M | 34.12M | 82.18M | 67.81K | |
| P/E ratio | -5.87 | -8.85 | 3.3 | -6.95 | -0.64 | |
| Price to sales ratio | 1.44 | 0.74 | 0.05 | 0.98 | 0.17 | |
| POCF ratio | -34.22 | -6.1 | -0.24 | -7.8 | -0.59 | |
| PFCF ratio | -25.85 | -5.35 | -0.23 | -6.93 | -0.58 | |
| P/B Ratio | -16.04 | -4.52 | -0.65 | 12.64 | 0.22 | |
| PTB ratio | -16.04 | -4.52 | -0.65 | 12.64 | 0.22 | |
| EV to sales | 1.86 | 1.22 | 0.62 | 1.46 | 0 | |
| Enterprise value over EBITDA | -59.15 | 130 | 10.72 | -19.92 | -0.01 | |
| EV to operating cash flow | -44.33 | -10.12 | -2.97 | -11.58 | 0 | |
| EV to free cash flow | -33.49 | -8.87 | -2.94 | -10.29 | 0 | |
| Earnings yield | -0.17 | -0.11 | 0.3 | -0.14 | -1.57 | |
| Free cash flow yield | -0.04 | -0.19 | -4.29 | -0.14 | -1.73 | |
| Debt to equity | -5 | -2.99 | -7.7 | 6.19 | 0.3 | |
| Debt to assets | 0.8 | 0.81 | 0.73 | 0.55 | 0.18 | |
| Net debt to EBITDA | -13.48 | 51.64 | 9.87 | -6.5 | 0.92 | |
| Current ratio | 0.82 | 0.75 | 1.17 | 1.37 | 2.58 | |
| Interest coverage | -0.18 | -0.01 | 0.97 | -1.27 | -1.88 | |
| Income quality | 0.17 | 1.45 | -14.01 | 0.89 | 1.08 | |
| Dividend Yield | 0 | 0 | 0 | 0.14 | 3.64 | |
| Payout ratio | 0 | 0 | 0 | -0.96 | -2.31 | |
| Sales general and administrative to revenue | 0.1 | 0.09 | 0.08 | 0.21 | 0.25 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | 0.32 | 0.14 | 0.01 | 0.13 | 0.03 | |
| Capex to revenue | -0.01 | -0.02 | 0 | -0.02 | -0.01 | |
| Capex to depreciation | -11.46 | -1.7 | -0.3 | -1.98 | -2.03 | |
| Stock based compensation to revenue | 0.01 | 0 | -0.02 | 0.1 | 0 | |
| Graham number | 48.86 | 41.25 | 16.51 | 42.64 | 57.61 | |
| ROIC | -0.09 | 0 | 0.06 | -0.14 | -0.15 | |
| Return on tangible assets | -0.44 | -0.14 | 0.02 | -0.16 | -0.21 | |
| Graham Net | -28.41 | -40.25 | -47.71 | -31.33 | 7.21 | |
| Working capital | -3.93M | -7.06M | 5.98M | 10.95M | 34.3M | |
| Tangible asset value | -3.61M | -6.72M | -4.39M | 3.89M | 38.95M | |
| Net current asset value | -5.67M | -9.16M | -7.23M | -4.17M | 27.66M | |
| Invested capital | -5 | -2.99 | -7.7 | 6.19 | 0.3 | |
| Average receivables | 3.19M | 7.11M | 18.09M | 28.52M | 28.27M | |
| Average payables | 3.86M | 7.25M | 10.27M | 12.05M | 12.02M | |
| Average inventory | 3.15M | 3.34M | 3.38M | 3.22M | 3.3M | |
| Days sales outstanding | 48.65 | 85.26 | 177.27 | 195.59 | 191.37 | |
| Days payables outstanding | 62.46 | 86.77 | 92.31 | 92.39 | 98 | |
| Days of inventory on hand | 33.71 | 35.21 | 25.38 | 23.98 | 28.38 | |
| Receivables turnover | 7.5 | 4.28 | 2.06 | 1.87 | 1.91 | |
| Payables turnover | 5.84 | 4.21 | 3.95 | 3.95 | 3.72 | |
| Inventory turnover | 10.83 | 10.37 | 14.38 | 15.22 | 12.86 | |
| ROE | 2.73 | 0.51 | -0.2 | -1.82 | -0.35 | |
| Capex per share | -0.95 | -1.27 | -0.22 | -1.36 | -0.2 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 12.06 | 1.21 | 1.16 | 1.14 | 1.02 | |
| Net income per share | -1.98 | -1.08 | -0.04 | -0.09 | -0.27 | |
| Operating cash flow per share | -1.53 | -1.03 | -0.6 | -0.53 | -0.36 | |
| Free cash flow per share | -1.54 | -1.04 | -0.6 | -0.85 | -0.53 | |
| Cash per share | 0.32 | 2.08 | 1.14 | 0.21 | 0.19 | |
| Book value per share | 5.18 | 3.97 | 4.18 | 4.07 | 3.54 | |
| Tangible book value per share | 4.49 | 3.9 | 4.12 | 3.72 | 3.22 | |
| Share holders equity per share | 5.18 | 3.97 | 4.18 | 4.07 | 3.54 | |
| Interest debt per share | 23.98 | 1.37 | 0.93 | 0.9 | 0.87 | |
| Market cap | 5.11M | 45.53M | 37.58M | 32.35M | 19.76M | |
| Enterprise value | 27.92M | 36.8M | 35.3M | 39.58M | 28.19M | |
| P/E ratio | -0.65 | -1.05 | -20.43 | -8.24 | -1.47 | |
| Price to sales ratio | 0.43 | 3.78 | 3.04 | 2.62 | 1.54 | |
| POCF ratio | -3.34 | -4.41 | -5.92 | -5.66 | -4.37 | |
| PFCF ratio | -3.33 | -4.4 | -5.9 | -3.53 | -2.96 | |
| P/B Ratio | 0.99 | 1.15 | 0.85 | 0.73 | 0.44 | |
| PTB ratio | 0.99 | 1.15 | 0.85 | 0.73 | 0.44 | |
| EV to sales | 2.32 | 3.05 | 2.86 | 3.2 | 2.2 | |
| Enterprise value over EBITDA | -117.99 | -3.85 | -14.96 | -17.81 | -10.66 | |
| EV to operating cash flow | -18.27 | -3.57 | -5.56 | -6.92 | -6.23 | |
| EV to free cash flow | -18.2 | -3.56 | -5.54 | -4.32 | -4.23 | |
| Earnings yield | -0.39 | -0.24 | -0.01 | -0.03 | -0.17 | |
| Free cash flow yield | -0.3 | -0.23 | -0.17 | -0.28 | -0.34 | |
| Debt to equity | 4.49 | 0.3 | 0.22 | 0.21 | 0.24 | |
| Debt to assets | 0.51 | 0.18 | 0.14 | 0.14 | 0.15 | |
| Net debt to EBITDA | -96.4 | 0.91 | 0.96 | -3.25 | -3.19 | |
| Current ratio | 1.05 | 2.58 | 2.73 | 2.19 | 2.06 | |
| Interest coverage | -0.45 | -4.42 | -19.73 | -10.55 | -19.95 | |
| Income quality | 0.77 | 0.95 | 13.8 | 5.83 | 1.35 | |
| Dividend Yield | 0 | 0.58 | 0 | 0 | 0.01 | |
| Payout ratio | 0 | -2.42 | 0 | 0 | -0.03 | |
| Sales general and administrative to revenue | 0.16 | 0.64 | 0.25 | 0.25 | 0.3 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.06 | 0.06 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0.6 | 0.47 | |
| Capex to revenue | 0 | 0 | 0 | -0.28 | -0.17 | |
| Capex to depreciation | -0.05 | 0.23 | -0.25 | -26.98 | -8.63 | |
| Stock based compensation to revenue | 0 | 0 | 0.01 | 0.05 | 0.01 | |
| Graham number | 15.19 | 9.84 | 2.02 | 2.88 | 4.6 | |
| ROIC | -0.01 | -0.14 | -0.04 | -0.05 | -0.05 | |
| Return on tangible assets | -0.04 | -0.16 | -0.01 | -0.02 | -0.05 | |
| Graham Net | -17.53 | 1.39 | 0.96 | 0.03 | 0.04 | |
| Working capital | 1.95M | 34.3M | 32.08M | 23.98M | 23.9M | |
| Tangible asset value | 4.47M | 38.95M | 43.69M | 40.26M | 40.5M | |
| Net current asset value | -1.62M | 27.66M | 27M | 19.66M | 19.53M | |
| Invested capital | 4.49 | 0.3 | 0.22 | 0.21 | 0.24 | |
| Average receivables | 28.24M | 26.99M | 26.3M | 26.57M | 28.17M | |
| Average payables | 11.29M | 11.66M | 11.41M | 11.26M | 12.14M | |
| Average inventory | 3.79M | 3.72M | 3.88M | 4.55M | 5.38M | |
| Days sales outstanding | 206.65 | 197.14 | 191.01 | 196.03 | 206.42 | |
| Days payables outstanding | 100.35 | 92.35 | 86.09 | 91.7 | 98.04 | |
| Days of inventory on hand | 35.03 | 26.74 | 33.97 | 37.84 | 46.21 | |
| Receivables turnover | 0.44 | 0.46 | 0.47 | 0.46 | 0.44 | |
| Payables turnover | 0.9 | 0.97 | 1.05 | 0.98 | 0.92 | |
| Inventory turnover | 2.57 | 3.37 | 2.65 | 2.38 | 1.95 | |
| ROE | -0.38 | -0.27 | -0.01 | -0.02 | -0.08 | |
| Capex per share | -0.01 | 0 | 0 | -0.32 | -0.17 |
COSM Frequently Asked Questions
What is Cosmos Holdings Inc. stock symbol ?
Cosmos Holdings Inc. is a US stock , located in Chicago of Il and trading under the symbol COSM
What is Cosmos Holdings Inc. stock quote today ?
Cosmos Holdings Inc. stock price is $0.6077 today.
Is Cosmos Holdings Inc. stock public?
Yes, Cosmos Holdings Inc. is a publicly traded company.
Company Profile
- Volume Average 286.83K
- Market Capitalization 11.94M
- Employee 102
- CEO Mr. Grigorios Siokas
- Headquarters Chicago,IL,US
- IPO Date 2010-07-23
-
Website
https://www.cosmosholdingsinc.com 
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
